| Popis: |
Since the discovery of the nucleic acid, molecular biology has made tremendous progresses, achieving a lot of results. Despite this, there is still a gap between the classical and traditional medical approach and the molecular world. Inspired by the incredible wealth of data generated by the "omics"-driven techniques and the “high-trouhgput technologies” (HTTs), I have tried to develop a protocol that could reduce the actually extant barrier between the phenomenological medicine and the molecular medicine, facilitating a translational shift from the lab to the patient bedside. I also felt the urgent need to integrate the most important omics sciences, that is to say genomics and proteomics. Nucleic Acid Programmable Protein Arrays (NAPPA) can do this, by utilizing a complex mammalian cell free expression system to produce proteins in situ. In alternative to fluorescent-labeled approaches a new label free method, emerging from the combined utilization of three independent and complementary nanobiotechnological approaches, appears capable to analyze gene and protein function, gene-protein, gene-drug, protein-protein and protein-drug interactions in studies promising for personalized medicine. Quartz Micro Circuit nanogravimetry (QCM), based on frequency and dissipation factor, mass spectrometry (MS) and anodic porous alumina (APA) overcomes indeed the limits of correlated fluorescence detection plagued by the background still present after extensive washes. Work is in progress to further optimize this approach a homogeneous and well defined bacterial cell free expression system able to realize the ambitious objective to quantify the regulatory gene and protein networks in humans. Implications for personalized medicine of the above label free protein array using different test genes and proteins are reported in this PhD thesis. |
